期刊文献+

MPC30-DEA70载AMO-miR-222对大鼠颈总动脉球囊损伤后血管狭窄的影响

Effects of AMO-miR-222 Carried by MPC30-DEA70 on Rats' Hemadostenosis after Common Arteria Carotis Balloon Injury
原文传递
导出
摘要 目的:阳离子磷酸胆碱聚合物(MPC30-DEA70)为非病毒类转基因载体,可与AMO-mi R-222络合,通过导管球囊系统将MPC30-DEA70/AMO-mi R-222基因复合物导入大鼠颈内动脉球囊损伤处,观察对血管平滑肌细胞增生及血管狭窄程度的影响。方法:90只雄性SD大鼠随机分为未损伤组、多聚赖氨酸(PLL组)、MPC30-DEA70/AMO-mi R-222组、PLL/AMO-mi R-222组、PLL/MPC30-DEA70组、AMO-mi R-222组、单纯损伤组、PLL载P/A=3:1组和P/A=5:1组,每组各10只。构建大鼠颈总动脉球囊损伤模型,予血管损伤段行PLL、MPC30-DEA70/AMO-mi R-222、PLL/AMO-mi R-222、PLL/MPC30-DEA70、AMO-mi R-222、PLL载P/A=3:1和P/A=5:1复合物的转运。4周后通过光学显微镜观察HE染色血管段组织形态学改变。Western blot法检测各组血管段p57Kip2、p27Kip1蛋白的表达情况。RT-PCR法检测各组血管段mi R222扩增情况。结果:光学显微镜下,多聚赖氨酸(PLL组)、裸MPC30-DEA70/AMO-mi R-222组、PLL/AMO-mi R-222组、PLL/MPC30-DEA70组、AMO-mi R-222组、MPC30-DEA70组可见内膜显著增生,新生内膜/中膜比值无组间差异,较PLL载P/A=3:1组和P/A=5:1组有组间差异,后两组比较无组间差异,未损伤组未见新生内膜增殖。Western blot法检测显示PLL载P/A=3:1组和P/A=5:1组P57kip2、P27kip1蛋白表达含量较未损伤组降低(P<0.05),较余六组增高(P<0.05),组间比较无显著差异(P>0.05)。RT-PCR法检测显示,mi R-222表达在未损伤组很低,PLL载P/A=3:1组和P/A=5:1组增高,余六组过表达(组间比较无显著差异)。结论:MPC30-DEA70可与AMO-mi R-222络合,有效抑制球囊损伤后血管mi R222表达,从而抑制新生内膜增生及血管狭窄。 Objective: As a non-viral transgenic carrier, the cationic phosphorylcholine polymer(MPC30-DEA70) can form a complexation with AMO-miR-222. The MPC30-DEA70/AMO-miR-222 gene compound is imported through catheter-balloon system into places where rats' internal arteria carotid balloon injury occurs to observe their effects on vascular smooth muscle cell proliferation and hemadostenosis. Methods: 90 male SD rats are randomly divided into 9 groups with 10 rats per group, as the groups respectively are: the uninjured group, polylysine group(PLL group), nude MPC30-DEA70/AMO-miR-222 group, PLL/AMO-miR-222 group, PLL/MPC30-DEA70 group, AMO-miR-222 group, only injured group, PLL-loaded P/A =3:1 group and P/A=5:1 group. Rats' common arteria carotis balloon injury model is built to transfer PLL, MPC30-DEA70/AMO-miR-222, PLL/AMO-miR-222, PLL/MPC30-DEA70, AMO-miR-222, MPC30-DEA70, PLL-loaded P/A=3:1 and P/A=5:1 compounds for injured vascular. Four weeks later, histologic changes of HE stained blood vessel will be observed by optical microscope. The proteins expressions of p57Kip2 and p27Kip1 in blood vessels of those groups are detected by Western blot method. Amplification of miR222 in blood vessels of those groups is detected by RT-PCR method.Results: Under optical microscope, remarkable intimal hyperplasia can be observed in the polylysine(PLL) group, nude MPC30-DEA70/AMO-miR-222 group, PLL/AMO-miR-222 group, PLL/MPC30-DEA70 group, AMO-miR-222 and MPC30-DEA70, while the ratio of neointima/medial membrance among those groups shows no inter-group difference; however, compared with that of PLL-loaded P/A=3:1 and P/A=5:1 two groups, which are identical between the two groups, the ratio shows no difference; no neointimal hyperplasia is observed in the uninjured group. According to the Western blot method, compared with the uninjured group(P〈0.05), the expressed contents of protein P57kip2 and P27kip1 in PLL loaded P/A=3:1 group and P/A=5:1 group are lower but higher than that of the
出处 《现代生物医学进展》 CAS 2017年第1期36-41,共6页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30800219 30670557) 江苏省高校自然科学基金项目(08KJD320013) 徐州医学院院长专项人才基金项目(07KJZ26)
关键词 磷酸胆碱聚合物 反义miR-222 内膜增生 血管狭窄 Phosphorylcholine Polymer Antisense Mir-222 Intimal Hyperplasia Hemadostenosis
  • 相关文献

参考文献6

二级参考文献36

  • 1WANG Xiao-dan,CHEN Xiang-mei,WANG Jian-zhong,HONG Quan,FENG Zhe,FU Bo,ZHOU Feng,WANG Feng-yang,FAN Dai-ming.Signal transducers and activators of transcription 3 mediates up-regulation of angiotensin ll-induced tissue inhibitor of metalloproteinase-1 expression in cultured human senescent fibroblasts[J].Chinese Medical Journal,2006(13):1094-1102. 被引量:7
  • 2汤鸿.清洗和存放盖玻片的几点体会[J].毒理学杂志,2006,20(4):271-271. 被引量:5
  • 3干耀恺,戴尅戎,张蒲,汤亭亭,郝永强,唐坚,史定伟,王友,孙月华,朱振安.应用富集骨髓干细胞技术治疗骨缺损[J].中华骨科杂志,2006,26(11):721-727. 被引量:31
  • 4徐蕴,肖琼,田铧,张立平,田广平.细胞外基质对大鼠MSCs生物学活性的影响[J].中国现代普通外科进展,2007,10(1):26-28. 被引量:4
  • 5Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the“ real world” : the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.Circulation, 2004, 109:190-193. 被引量:1
  • 6Tanabe K, Serruys PW, Degertekin M, et al. Chronic arterial responses to polymer-controlled paelitaxel-eluting stents: comparison with bare metal stents by serial intravaseular ultrasound analyses: data from the randomized TAXUS-II trial. Circulation, 2004, 109:196-200. 被引量:1
  • 7Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release polymer-based, paclitaxel-eluting TAXUS stent. The TAXUS-IV trial. Circulation, 2004, 109 : 1942-1947. 被引量:1
  • 8Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restonsis. Circulation, 2004, 109:634-640. 被引量:1
  • 9Schampaert E, Cohen EA, Schluter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long denovo lesion in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol, 2004, 43:1110-1115. 被引量:1
  • 10Schofer J, Schiuter M, Gershliek AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet, 2003, 362:1860-1863. 被引量:1

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部